Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

15/05/2024 07:30

May 15 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2024        Mar 31, 2023     Dec 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            648 mln             370 mln           4.54     
                 (+75.1 pct)         (+9.2 pct)      (+138.5 pct) 
  Operating        44 mln           loss 108 mln        313 mln   
  Recurring      loss 77 mln        loss 110 mln        290 mln   
  Net            loss 78 mln        loss 148 mln        236 mln   
  EPS           loss 3.61 yen       loss 6.88 yen      10.91 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T